Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
ADMA Biologics
ADMA
$1.96B
| $451K | ﹤0.01% |
153,627
-19,627
| -11% | -$56.4K |
|
2877
RGC Resources
RGCO
$223M
| $450K | ﹤0.01% |
18,591
+93
| +0.5% | +$2.37K |
|
2878
Comscore
SCOR
$106M
| $449K | ﹤0.01% |
7,231
+1,237
| +21% | +$74.2K |
|
2879
Hurco Companies Inc
HURC
$135M
| $448K | ﹤0.01% |
16,015
| – | – |
|
|
CSTR
2880
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $448K | ﹤0.01% |
37,262
+3,788
| +11% | +$40.9K |
|
2881
Covenant Logistics
CVLG
$894M
| $447K | ﹤0.01% |
61,900
+2,878
| +5% | +$14.7K |
|
2882
Fidelity D&D Bancorp
FDBC
$306M
| $447K | ﹤0.01% |
9,291
+2,304
| +33% | +$92.3K |
|
|
CBMG
2883
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $446K | ﹤0.01% |
29,735
+1,209
| +4% | +$17.3K |
|
2884
OptimizeRx
OPRX
$114M
| $444K | ﹤0.01% |
34,060
+2,060
| +6% | +$22.4K |
|
|
BREW
2885
DELISTED
Craft Brew Alliance, Inc.
BREW
| $442K | ﹤0.01% |
28,678
+310
| +1% | +$4.73K |
|
2886
BeyondSpring
BYSI
$47.3M
| $441K | ﹤0.01% |
29,211
+1,906
| +7% | +$29.1K |
|
2887
Dyadic International
DYAI
$38.3M
| $439K | ﹤0.01% |
+50,620
| New | +$337K |
|
2888
AMES National
ATLO
$271M
| $438K | ﹤0.01% |
22,172
+1,142
| +5% | +$22.3K |
|
2889
Choiceone Financial
COFS
$509M
| $436K | ﹤0.01% |
+14,717
| New | +$418K |
|
|
SIEN
2890
DELISTED
Sientra, Inc.
SIEN
| $435K | ﹤0.01% |
11,234
+2,053
| +22% | +$61.9K |
|
2891
American Superconductor
AMSC
$1.42B
| $433K | ﹤0.01% |
53,216
+100
| +0.2% | +$654 |
|
2892
Boston Omaha
BOC
$428M
| $433K | ﹤0.01% |
27,011
+2,375
| +10% | +$39.6K |
|
2893
First Internet Bancorp
INBK
$257M
| $433K | ﹤0.01% |
25,996
+1,315
| +5% | +$20.6K |
|
|
GBL
2894
DELISTED
GAMCO Investors, Inc.
GBL
| $433K | ﹤0.01% |
32,515
-12
| -0% | -$150 |
|
|
HUD
2895
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $433K | ﹤0.01% |
88,731
+5,101
| +6% | +$26.6K |
|
|
LUNA
2896
DELISTED
Luna Innovations Incorporated
LUNA
| $433K | ﹤0.01% |
74,019
+62,320
| +533% | +$406K |
|
|
OYST
2897
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $429K | ﹤0.01% |
14,832
+2,833
| +24% | +$85.4K |
|
2898
Genasys
GNSS
$76.1M
| $425K | ﹤0.01% |
87,381
+70,743
| +425% | +$312K |
|
2899
Abeona Therapeutics
ABEO
$366M
| $423K | ﹤0.01% |
5,791
-215
| -4% | -$14.9K |
|
2900
Fulgent Genetics
FLGT
$470M
| $422K | ﹤0.01% |
+26,343
| New | +$403K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.